risedronic acid has been researched along with Wet Macular Degeneration in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Wet Macular Degeneration: A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mammo, Z | 1 |
| Guo, M | 1 |
| Maberley, D | 1 |
| Matsubara, J | 1 |
| Etminan, M | 1 |
1 other study available for risedronic acid and Wet Macular Degeneration
| Article | Year |
|---|---|
Oral Bisphosphonates and Risk of Wet Age-Related Macular Degeneration.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Case-Control Studies; Diphosphonates; Fe | 2016 |